AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF ZONISADE (zonisamide oral suspension) Read more
AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine Read more
Incyte Announces FDA Approval of Opzelura (ruxolitinib) Cream for the Treatment of Vitiligo Read more
Amylyx Pharmaceuticals Announces Partnership Agreement with Sunnybrook Research Institute to Identify Novel Drug Candidates for Neurodegenerative Diseases Read more
Therapeutic Goods Administration Grants Provisional Approval for Moderna’s COVID-19 Vaccine in Children Aged Six Months to Five Years Read more
Everest Medicines Announces European Commission Grants Approval of Kinpeygo® for Adults with Primary IgA Nephropathy to our Partner Calliditas Therapeutics Read more
Endo Announces Agreement for Paladin Labs to Develop, Commercialize and Supply Quoin Pharmaceuticals’ QRX003 in Canada Read more
FDA Grants Orphan Drug Designation (ODD) Status to NeoImmuneTech’s NT-I7 for the treatment of Glioblastoma Multiforme Read more
SK Biopharmaceuticals, Eurofarma Enter into Licensing Agreement for Cenobamate in Latin America Read more